Case Letter

Necrolytic Migratory Erythema With Recalcitrant Dermatitis as the Only Presenting Symptom

Author and Disclosure Information

Practice Points

  • Recalcitrant dermatitis may be a symptom of internal malignancy.
  • Glucagon levels are helpful in identifying glucagonomas of the pancreas.
  • Although surgical excision is the preferred treatment of glucagonomas, azathioprine also can control dermatitis associated with necrolytic migratory erythema.


 

References

To the Editor:

A 52-year-old man presented with recalcitrant dermatitis of 6 years’ duration. He was otherwise in excellent health. On initial presentation, physical examination revealed symmetrical, erythematous, blanching plaques with areas of erosions and overlying hemorrhagic crust on the eyebrows, scalp, back, dorsal aspects of the hands, axillae, abdomen (Figure), buttocks, groin, scrotum, pubis, and lower legs. Some areas showed slight necrosis. He denied any fevers, chills, night sweats, cough, chest pain, shortness of breath, dizziness, lightheadedness, weight loss, or appetite change.

Scaly plaques on the lower abdomen and inguinal crease characteristic of necrolytic migratory erythema.

Throughout the disease course the patient had visited numerous dermatologists seeking treatment. He had response to higher doses of oral prednisone (80 mg taper), but the condition would recur at the end of an extended taper. Treatment with narrowband UVB, mycophenolate mofetil, methotrexate, acitretin, topical clobetasol, and topical pimecrolimus provided no relief. Eventually he was placed on azathioprine 100 mg twice daily, which led to near-complete resolution. Outbreaks continued every few months and required courses of prednisone.

Multiple biopsies over the years revealed subacute spongiotic or psoriasiform dermatitis. At multiple visits it was noted that during flares there were areas of crusting and mild necrosis, which led to an extensive biochemical investigation. The glucagon level was markedly elevated at 630 ng/L (reference range, 40–130 ng/L), as was insulin at 71 μIU/mL (reference range, 6–27 μIU/mL). Complete blood cell counts over the disease course showed mild normochromic normocytic anemia. The abnormal laboratory findings led to computed tomography of the abdomen, which revealed a mass in the body of the pancreas measuring 3×3.8 cm. After computed tomography, the patient underwent a laparoscopic distal pancreatectomy and splenectomy. Histologic examination revealed a well-differentiated pancreatic endocrine tumor (glucagonoma) confined to the pancreas. After the surgery, the patient’s rash resolved within a few days and he discontinued all medications.

Pages

Recommended Reading

What Is Your Diagnosis? Stinkbug Staining
MDedge Dermatology
Allergic Contact Dermatitis, Part 4
MDedge Dermatology
An Eruption While on Total Parenteral Nutrition
MDedge Dermatology
Therapies to Improve the Cosmetic Symptoms of Atopic Dermatitis
MDedge Dermatology
Prolonged Pustular Eruption From Hydroxychloroquine: An Unusual Case of Acute Generalized Exanthematous Pustulosis
MDedge Dermatology
Night of the Living Thrips: An Unusual Outbreak of Thysanoptera Dermatitis
MDedge Dermatology
Atopic Dermatitis Treatments Moving Forward: Report From the AAD Meeting
MDedge Dermatology
Patch Testing: Working With Patients to Find a Relevant Allergen
MDedge Dermatology
A Practical Overview of Pediatric Atopic Dermatitis, Part 2: Triggers and Grading
MDedge Dermatology
A Practical Overview of Pediatric Atopic Dermatitis, Part 3: Differential Diagnosis, Comorbidities, and Measurement of Disease Burden
MDedge Dermatology

Related Articles